Despite the summer heat and restrictive measures, business activity goes on! Especially when it comes to the industry’s largest online event - the EAEU PHARMA WEEK, which is taking place on these days, June 17-19. This extraordinary event can’t be missed because the organizers have prepared a highly topical program, an immersion course for pharmaceutical professionals.

Many expert communities have already discussed what changes in life the coronavirus brought about. What lessons have we learned and how to live in a changed world? Today, it is time to expand horizons and plan for the future — headline forum topics: clinical trials in the EAEU, pharmacovigilance, and registration of medicines.

Over 50 speakers, 300 participants in just three days, examined questions about the effect of coronavirus on clinical trials, the quality of remote monitoring and data obtained during the pandemic, and whether legislative changes are needed to conduct clinical trials. In addition to the remote work format, we also faced for the first time the need for accelerated medication development procedures, remote communication with regulating authorities as well as a shortage of medicines (restrictive measures had an effect here when imported raw materials for production cannot cross borders).

We thank the organizers of the conference for the excellent reports delivered by the speakers and the opportunity to get information first hand. Undoubtedly, the world will never be the same as before. It is essential to exchange experiences, opinions, and best practices in a timely manner to jointly minimize the consequences of the processes that we are witnessing during the pandemic.